Phasegenomics

The new suite of products unlocks greater access to deep metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications. SEATTLE - June 19, 2025 - Phase Genomics, Inc., a leader in genomic

Phase Genomics continues to pioneer genomic innovation, driving advancements in human health and life science research over another impactful year. Our efforts range from developing novel tools for detecting chromosomal abnormalities to managing the world

SEATTLE - Phase Genomics, Inc., a leading innovator at the forefront of genomics technology development, today announced the appointment of David Shoultz, PhD, MBA as the company's first Chief Business Officer. A strategic addition to the executive suite,

Data shows proprietary technology enables lower cost and higher efficacy through new induced-dysbiosis vaccine targeting a parasite's microbiome The salmon aquaculture industry has - to put it mildly - a lousy problem. Sea lice have been sucking salmon dr

SEATTLE (March, 4, 2024) - Phase Genomics, Inc., a leading innovator at the forefront of genomics technology development, today announced $1.5MM in new funding from the Bill & Melinda Gates Foundation to fuel a new antimicrobial discovery platform. Levera

Decades of antibiotic use - and abuse - are triggering a global rise in antibiotic resistance and limiting the usefulness of these life-saving drugs. In a nod to the adage, "The enemy of my enemy is my friend," a solution may lie with bacteria's oldest ad

New genomic technology reveals the parental past of "ancient asexuals," paving a route to crop engineering and soil remediation with symbiotic fungi In a warming, crowded world, we need more help than ever from plants. But maximizing the bounty from crops

Another year has flown by with great accomplishments and advancements from researchers around the world wielding the latest in proximity ligation technology. As the year draws to a close, we at Phase Genomics would like to highlight some of the milestones

$2.5M in funding from the National Cancer Institute and Andy Hill CARE Fund will accelerate Phase Genomics' proprietary OncoTerra platform toward clinical use, unlocking new genome-wide cytogenetic insights for acute myeloid leukemia and colorectal cancer

Hydrothermal mat sampling aboard R/V Roger Revelle using ROV Jason. Credit: R/V Roger Revelle, Scripps institute of Oceanography. For decades, biologists largely studied microbes and their viruses in isolation, nurtured in laboratory cultures. Yet, to par